Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 2, 2009

Toxin B Found to Be the Key to C. Difficile’s Virulence

  • Researchers from Australia and Loyola University Chicago Stritch School of Medicine have figured out that Toxin B produced by C. difficile is the more important toxin compared to Toxin A. “For 20 years, we have been focusing on Toxin A,” says Dale Gerding, M.D., co-author of the study. “But it turns out the real culprit is Toxin B.”

    The team noted that a human clinical trial using a drug that bound Toxin A more than it bound Toxin B failed to treat C. diff effectively. They thus engineered mutant strains of the bacteria to do further testing.

    “It turns out that in the strain in which Toxin A was knocked out, the organism was fully virulent,” explains Stuart Johnson, Ph.D., associate professor of medicine at Loyola University Chicago Stritch School of Medicine. When they knocked the Toxin B out in another set of experiments, the organism didn't cause disease.

    These findings appear in the March 1 edition of Nature.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »